Drug Profile
Research programme: liposome formulated vaccines - Telormedix
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Telormedix
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants; Toll-like receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Streptococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Streptococcal-infections in Switzerland (Parenteral, Liposomal)
- 05 Sep 2011 Early research in Streptococcal infections in Switzerland (Parenteral)